In line with our study, previous study have shown that rapamycin could inhibit the proliferation of glioma cells by inducing autophagy (Bray et al., 2012), which contributed to the anti-glioma effect of EMAP II combined with rapamycin. The gene discussed is AIMP1; the disease is central nervous system cancer.